Lenacapavir Sodium

Preferred Label : Lenacapavir Sodium;

NCIt related terms : Sunlenca;

NCIt definition : The sodium salt form of lenacapavir, an inhibitor of human immunodeficiency virus type 1 (HIV-1) capsid function, with activity against HIV. Upon administration, lenacapavir targets and binds to the interface between HIV capsid protein (p24) subunits in hexamers. This inhibits capsid function, including capsid-mediated nuclear uptake of preintegration complexes, virion production and proper capsid core formation, thereby inhibiting HIV-1 replication.;

UNII : BDT58WJ9WE;

CAS number : 2283356-12-5;

Drug name : Sunlenca;

NCI Metathesaurus CUI : CL1778580;

Details

Origin ID

C186395;

UMLS CUI

C5670506;

Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
has_free_acid_or_base_form
- Lenacapavir [NCIt concept]
is_salt_form_of
- Lenacapavir [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients